Monica Shaw
Director/Board Member at AC IMMUNE SA
Net worth: 27 084 $ as of 31/03/2024
Profile
Monica Shaw is currently an Independent Non-Executive Director at AC Immune SA, a Senior Vice President-Major Markets at Bristol Myers Squibb Co., and the EVP-Head Region Europe, Canada & Australia at LEO Pharma.
A.
She is also a Member of The Royal College of Physicians and the VP-Commercial & Head-Asia Pacific Region at ViiV Healthcare Co. In the past, she was the Chief Executive Officer at Oncopeptides AB and the Medical Director & Chief Scientific Officer-UK at Novartis AG.
Dr. Shaw received a doctorate degree from Oxford University Medical School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
AC IMMUNE SA
0.01% | 01/03/2024 | 9,150 ( 0.01% ) | 27 084 $ | 31/03/2024 |
Monica Shaw active positions
| Companies | Position | Start |
|---|---|---|
| AC IMMUNE SA | Director/Board Member | 29/10/2021 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 06/09/2023 |
| The Royal College of Physicians | Corporate Officer/Principal | - |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Corporate Officer/Principal | - |
| ViiV Healthcare Co. | Corporate Officer/Principal | - |
Former positions of Monica Shaw
| Companies | Position | End |
|---|---|---|
| ONCOPEPTIDES AB | Chief Executive Officer | 07/08/2023 |
| Novartis AG /U.S. Biologics Manufacturing Operation/ | Chief Tech/Sci/R&D Officer | - |
Training of Monica Shaw
| Oxford University Medical School | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| AC IMMUNE SA | Health Technology |
| ONCOPEPTIDES AB | Health Technology |
| Private companies | 3 |
|---|---|
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Health Technology |
| Novartis AG /U.S. Biologics Manufacturing Operation/ | Health Technology |
| ViiV Healthcare Co. |
- Stock Market
- Insiders
- Monica Shaw
